Ceftobiprole medocaril sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ceftobiprole medocaril sodium and what is the scope of freedom to operate?
Ceftobiprole medocaril sodium
is the generic ingredient in one branded drug marketed by Basilea Pharm Allsch and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for ceftobiprole medocaril sodium
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Patent Applications: | 8 |
| DailyMed Link: | ceftobiprole medocaril sodium at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for ceftobiprole medocaril sodium
Generic Entry Date for ceftobiprole medocaril sodium*:
Constraining patent/regulatory exclusivity:
GENERATING ANTIBIOTIC INCENTIVES NOW Dosage:
POWDER;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Anatomical Therapeutic Chemical (ATC) Classes for ceftobiprole medocaril sodium
US Patents and Regulatory Information for ceftobiprole medocaril sodium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Basilea Pharm Allsch | ZEVTERA | ceftobiprole medocaril sodium | POWDER;INTRAVENOUS | 218275-001 | Apr 3, 2024 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Basilea Pharm Allsch | ZEVTERA | ceftobiprole medocaril sodium | POWDER;INTRAVENOUS | 218275-001 | Apr 3, 2024 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
